Linner Mars vs Otofonix Groove

The Linner Mars is a budget-priced OTC hearing aid released in 2023, earning a B grade with a SoundScore of 3.2/5 in our lab testing. At $399, it falls in the lower price tier of the OTC category but ranks #55 of 65 OTC devices tested, placing it in the bottom 17% of its category. This visible-in-ear device presents a mixed performance profile with notable strengths and significant weaknesses. Music streaming is a standout feature, scoring an excellent 4.6/5—a full 2.68 points above the category average. Feedback handling is also excellent at 5.0/5, meaning users can expect stable performance without whistling during normal use. However, speech clarity presents challenges. Speech in quiet scores a low 1.9/5, falling 0.85 points below the category average. Speech in noise performance is particularly limited at 1.0/5, sitting 0.46 points below average. Own-voice comfort also scores low at 1.0/5, which is 1.51 points below the category average—users may notice their own voice sounding unnatural or boomy. The Linner Mars may suit budget-conscious consumers who prioritize music and media streaming over speech understanding in challenging environments. However, buyers seeking better speech performance should consider alternatives like the Elehear Beyond or Apple AirPods Pro 2, which offer stronger overall sound scores in the same price range.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.